Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component

Annals of Surgical Oncology

Volumn 18, Issue 5, 2011, Pages 1342-1348

  Yu, Ke Da ^a   Wu, La Mu ^b   Liu, Guang Yu ^a   Wu, Jiong ^a   Di, Gen Hong ^a   Shen, Zhen Zhou ^a   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

^b Hami Diqu Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST DUCTAL CARCINOMA IN SITU WITH INVASION; BREAST DUCTAL CARCINOMA IN SITU WITH MICROINVASION; CANCER INVASION; CANCER LOCALIZATION; CANCER RELAPSE; CANCER SURGERY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 79955787989     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1407-3     Document Type: Article

References (20)

1. GD Leonard SM Swain 2004 Ductal carcinoma in situ, complexities and challenges J Natl Cancer Inst. 96 906 920 15199110 10.1093/jnci/djh164 (Pubitemid 38868137)
2. NN Baxter BA Virnig SB Durham TM Tuttle 2004 Trends in the treatment of ductal carcinoma in situ of the breast J Natl Cancer Inst. 96 443 448 15026469 10.1093/jnci/djh069 (Pubitemid 38443647)
3. L Fan Y Zheng KD Yu GY Liu J Wu JS Lu, et al. 2009 Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China Breast Cancer Res Treat. 117 409 416 19153831 10.1007/s10549-008-0303-z
4. KD Yu GH Di J Wu JS Lu KW Shen ZZ Shen, et al. 2007 Development and trends of surgical modalities for breast cancer in China: a review of 16-year data Ann Surg Oncol. 14 2502 2509 17564750 10.1245/s10434-007-9436-2 (Pubitemid 47389574)
5. SE Singletary C Allred P Ashley LW Bassett D Berry KI Bland, et al. 2002 Revision of the American Joint Committee on Cancer staging system for breast cancer J Clin Oncol. 20 3628 3636 12202663 10.1200/JCO.2002.02.026 (Pubitemid 34983222)
6. S Bianchi V Vezzosi 2008 Microinvasive carcinoma of the breast Pathol Oncol Res. 14 105 111 18493870 10.1007/s12253-008-9054-8
7. Y Okumura Y Yamamoto Z Zhang T Toyama T Kawasoe M Ibusuki, et al. 2008 Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion BMC Cancer 8 287 18837981 10.1186/1471-2407-8-287
8. Vieira CC, Mercado CL, Cangiarella JF, Moy L, Toth HK, Guth AA. Microinvasive ductal carcinoma in situ: Clinical presentation, imaging features, pathologic findings, and outcome. Eur J Radiol. 2008; in press.
9. RF Padmore B Fowble J Hoffman C Rosser A Hanlon AS Patchefsky 2000 Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience Cancer. 88 1403 1409 10717623 10.1002/(SICI)1097- 0142(20000315)88:6<1403::AID-CNCR18>3.0.CO;2-S 1:STN:280: DC%2BD3c7otlGhsQ%3D%3D (Pubitemid 30155178)
10. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees, et al. 2000 Molecular portraits of human breast tumours Nature. 406 747 752 10963602 10.1038/35021093 1:CAS:528:DC%2BD3cXmt1CnsLw%3D
11. T Sorlie CM Perou R Tibshirani T Aas S Geisler H Johnsen, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A. 98 10869 10874 11553815 10.1073/pnas.191367098 1:CAS:528:DC%2BD3MXntVGmsbo%3D (Pubitemid 32878711)
12. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A. 100 8418 8423 12829800 10.1073/pnas. 0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D (Pubitemid 36842560)
13. LA Carey CM Perou CA Livasy LG Dressler D Cowan K Conway, et al. 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA. 295 2492 2502 16757721 10.1001/jama.295.21.2492 1:CAS:528: DC%2BD28XlsV2rtLw%3D (Pubitemid 43854964)
14. CA Livasy CM Perou G Karaca DW Cowan D Maia S Jackson, et al. 2007 Identification of a basal-like subtype of breast ductal carcinoma in situ Hum Pathol. 38 197 204 17234468 10.1016/j.humpath.2006.08.017 1:CAS:528: DC%2BD2sXnslOitQ%3D%3D (Pubitemid 46096566)
15. WJ Yin JS Lu GH Di YP Lin LH Zhou GY Liu, et al. 2009 Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients Breast Cancer Res Treat. 115 325 333 18563552 10.1007/s10549-008-0096-0
16. P Robbins S Pinder N de Klerk H Dawkins J Harvey G Sterrett, et al. 1995 Histological grading of breast carcinomas: a study of interobserver agreement Hum Pathol. 26 873 879 7635449 10.1016/0046-8177(95)90010-1 1:STN:280: DyaK2Mzmt1ahtA%3D%3D
17. KD Yu ZZ Shen ZM Shao 2009 The immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" subgroup is not a surrogate for the normal-like subtype in breast cancer Breast Cancer Res Treat. 118 661 663 19714461 10.1007/s10549-009-0522-y 1:CAS:528: DC%2BD1MXhtlyls7%2FJ
18. L Wiechmann HM Kuerer 2008 The molecular journey from ductal carcinoma in situ to invasive breast cancer Cancer. 112 2130 2142 18383519 10.1002/cncr.23430 (Pubitemid 351628621)
19. A Hoque N Sneige AA Sahin DG Menter JW Bacus GN Hortobagyi, et al. 2002 Her-2/neu gene amplification in ductal carcinoma in situ of the breast Cancer Epidemiol Biomarkers Prev. 11 587 590 12050101 1:CAS:528:DC%2BD38Xltlant7k%3D (Pubitemid 34615167)
20. EK Latta S Tjan RK Parkes FP O'Malley 2002 The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast Mod Pathol. 15 1318 1325 12481013 10.1097/01.MP.0000038462.62634.B1 1:STN:280:DC%2BD38jhvVyhsg%3D%3D (Pubitemid 35463000)